Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportEducational Exhibits

FDG PET/CT imaging characteristics in multiple myeloma patients at staging and follow-up

M.Reza Fardanesh, Neetha Gandikota, Ajai Chari, Sundar Jagannath, Josef Machac, Sherif Heiba and Lale Kostakoglu
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1056;
M.Reza Fardanesh
1Radiology, Mount Sinai Medical Center, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neetha Gandikota
1Radiology, Mount Sinai Medical Center, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ajai Chari
2Hematology/Oncology, Mount Sinai Medical Center, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sundar Jagannath
2Hematology/Oncology, Mount Sinai Medical Center, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josef Machac
1Radiology, Mount Sinai Medical Center, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sherif Heiba
1Radiology, Mount Sinai Medical Center, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lale Kostakoglu
1Radiology, Mount Sinai Medical Center, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1056

Learning Objectives On FDG PET/CT imaging, 1. Identify different patterns of the disease presentation at staging. 2. Recognize findings for recurrence and post-therapy presentations. 3. Understand and identify the potential pitfalls.

Multiple myeloma (MM) is a plasma-cell malignancy, characterized by osteolytic lesions causing pathological fractures, cord compression and hypercalcemia. Depending on M-protein and plasma cell levels, disease spectrum varies from monoclonal gammopathy of undetermined significance (MGUS) to symptomatic MM. The bone lesions rarely heal even in complete remission. Sensitive imaging techniques are essential in the diagnosis, staging and restaging of MM. The Durie/Salmon-plus staging system incorporated FDG-PET or MRI information;focal lesion number, extent of bone marrow disease. The pattern of MM infiltration may be focal, multifocal or diffuse on FDG PET/CT. PET/CT is also helpful in detection of extramedullary MM. MM treatment protocol includes induction therapy followed by autologous stem cell transplantation (ASCT). The residual FDG activity after induction before ASCT portends a poor prognosis, prompting treatment changes. The detection of impending vertebral collapse, sequelae of prior fractures, detection of active MM in small lytic areas, differentiation of bone healing or arthritic changes from active MM, extramedullary MM or soft tissue components and infection is of crucial clinical value for management decisions. Bone marrow stimulation have PET characteristics similar to that of diffuse marrow infiltration posing a potential pitfall. In light of the increasing use of FDG PET/CT for MM staging and treatment monitoring, it is important to be familiarized with imaging findings and interpretative pitfalls to avoid false readings at both staging and restaging. This presentation will review most relevant PET/CT findings for MM by disease stage, treatment related findings, recurrence patterns and potential diagnostic pitfalls

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 53, Issue supplement 1
May 2012
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
FDG PET/CT imaging characteristics in multiple myeloma patients at staging and follow-up
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
FDG PET/CT imaging characteristics in multiple myeloma patients at staging and follow-up
M.Reza Fardanesh, Neetha Gandikota, Ajai Chari, Sundar Jagannath, Josef Machac, Sherif Heiba, Lale Kostakoglu
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1056;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
FDG PET/CT imaging characteristics in multiple myeloma patients at staging and follow-up
M.Reza Fardanesh, Neetha Gandikota, Ajai Chari, Sundar Jagannath, Josef Machac, Sherif Heiba, Lale Kostakoglu
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1056;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Educational Exhibits

  • Challenges in F-18 FDG PET/CT: Benign Osseous Hypermetabolic Lesions
  • Do They Work? Utilizing the "Hoshin Kanri" Process in the Nuclear Medicine Department
  • Early small bowel activity may predict rapid gastric transit on gastric emptying scintigraphy
Show more Educational Exhibits

MTA I: Educational Exhibits-Oncology

  • Simplified quantitative imaging techniques for analysis of dynamic PET/CT scans in response assessment: A promising approach for routine clinical use
  • 99mTc MAA hepatic perfusion scintigraphy prior to radioembolization - From the angio suite to the gamma camera
  • FDG PET/CT findings of relatively rare adrenal tumors
Show more MTA I: Educational Exhibits-Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire